American Century Companies Inc Clovis Oncology, Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $770,673 - $2.16 Million	-66,266 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$29.37 - $49.48 $7,166 - $12,073	-244 Reduced 0.37%	66,266 $1.95 Million
Q2 2018 Aug 08, 2018	SELL	$42.06 - $62.4 $17,959 - $26,644	-427 Reduced 0.64%	66,510 $3.02 Million
Q1 2018 May 03, 2018	BUY	$50.12 - $67.72 $740,873 - $1 Million	14,782 Added 28.34%	66,937 $3.53 Million
Q4 2017 Feb 02, 2018	SELL	$57.69 - $84.58 $1.05 Million - $1.55 Million	-18,277 Reduced 25.95%	52,155 $3.55 Million
Q3 2017 Nov 01, 2017	BUY	$67.17 - $84.81 $4.73 Million - $5.97 Million	70,432	70,432 $5.8 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.